YouTubeFacebookLinkedInTwitterinstagramrss

Press Releases

AVIA Names Linda Finkel as CEO

CHICAGO, IL, UNITED STATES - Oct 23, 2020 - AVIA, the nation’s leading digital transformation partner for healthcare organizations, announced that its board of directors has appointed AVIA President Linda Finkel to also serve as chief executive officer, effective November 1, 2020

BOC Sciences Lanuched A New Biotinylation Platform

SHIRLEY, NY, UNITED STATES - Oct 23, 2020 - Recently, BOC Sciences, a New York-based chemical and pharmaceutical supplier, announced to launch a new biotinylation technology platform for the scientific community

Profacgen Updated Its Pull Down Assay Service for Protein Interaction Study

SHIRLEY, NY, UNITED STATES - Oct 22, 2020 - Profacgen, with an organized team of scientists with extensive experience in the study of protein-protein interaction, recently updated its pull down assay service to help efficiently and specifically verify the predicted protein-protein interactions or identify novel interactions

Elsevier Signs Collaboration to Develop Novel Prediction Tool to Reduce Drug Development Safety Risk

LONDON, UNITED KINGDOM - Oct 22, 2020 - Elsevier, a global information analytics business specializing in science and health, today announced its collaboration with the pharmaceutical company Novartis to develop a safety margin risk assessment prediction tool, largely using PharmaPendium data

Aurinia Pharmaceuticals selects MyMeds&Me’s Reportum QuickStart platform to streamline drug safety reporting

LONDON, UK - Oct 21, 2020 - MyMeds&Me, a leading provider of drug safety software to transform the end-to-end pharmacovigilance process, have today announced that Aurinia Pharmaceuticals Inc

Alfa Chemistry Testing Lab Builds an Exclusive Regulatory Resource Section on Its Website

NY, NY - Oct 21, 2020 - For customers who are not familiar with industry regulations, Alfa Chemistry Testing Lab has recently built an exclusive section of regulatory resource section for them on its website for reference purposes

MDI Biological Laboratory Awarded $3.14 Million for Kidney Research

BAR HARBOR, ME, UNITED STATES - Oct 20, 2020 - The MDI Biological Laboratory has announced that it has received a grant of $3.14 million over five years from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), an institute of the National Institutes of Health (NIH), for the development of artificial kidney tissue to replace human kidney tissue that is lost to disease or injury

abeo Appoints Joe Ferro as Chief Technology and Innovation Officer

DALLAS, TX, UNITED STATES - Oct 20, 2020 - abeo, a leader in physician-focused billing and practice management solutions, today announced its appointment of Joe Ferro to Chief Technology and Innovation Officer

ATMPS advanced therapy blockchain platform has successful testing with NHS partners

LONDON, UNITED KINGDOM - Oct 20, 2020 - : ATMPS Ltd – a spinout of FarmaTrust announces that its Hataali blockchain platform has been successfully tested with University Hospitals Birmingham NHS Foundation Trust’s system interface

Optibrium Launches Cerella, a Novel Artificial Intelligence Platform for Active Learning in Drug Discovery

CAMBRIDGE, UNITED KINGDOM - Oct 20, 2020 - Optibrium today announced the launch of Cerella, an Artificial Intelligence (AI) software platform for drug discovery that delivers active learning using advanced deep learning methods

908 Devices Announces New Additions to Its Executive Team

BOSTON, MA, UNITED STATES - Oct 15, 2020 - 908 Devices, a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today announced the appointment of two Vice Presidents to its executive team, including Maura Fitzpatrick as the Vice President of Product Management and Marketing; and Kevin McCallion as the Vice President of Production and New Product Introduction

Bora Pharmaceuticals’ Bobby Sheng wins ‘CEO of the Year’ at CPhI Awards 2020

- Oct 15, 2020 - Bora Pharmaceuticals, a full-service contract development and manufacturing organisation (CDMO) which specialises in immediate and modified-release tablets and capsules, along with serialised packaging, announced that its Chairman and CEO, Bobby Sheng, was unveiled as ‘CEO of the Year’ at the CPhI Pharma Awards 2020

Dotmatics introduces Blueprint to provide self-service data analysis for medicinal and synthetic chemists

BISHOP'S STORTFORD, UNITED KINGDOM - Oct 14, 2020 - Dotmatics Ltd, a scientific informatics software and services company that is driving the automation of laboratory data workflows for scientific discovery and innovation research, today announced it has expanded its product portfolio to include Blueprint, a self-service, scientific visualization and analytics application for small molecule discovery

AffaMed Therapeutics Announces Merger with EverInsight Therapeutics and Appoints Dayao Zhao, M.D., Ph.D. as CEO

BELFORD, NJ, UNITED STATES - Oct 14, 2020 - SHANGHAI, China, Oct. 14, 2020 (GLOBE NEWSWIRE) -- AffaMed Therapeutics (“AffaMed”), a biopharmaceutical company focused on developing and commercializing transformative therapeutics to address ophthalmologic and central nervous system (CNS) disorders with high unmet medical need for patients in Greater China and beyond, today announced a definitive merger agreement with biopharmaceutical company EverInsight Therapeutics (“EverInsight”)

Partek Genomic Analysis Software Reaches New Citation High: Over 8,000 Peer-reviewed Articles

ST. LOUIS, MO, UNITED STATES - Oct 15, 2020 -   Partek Incorporated announced today that its software has been cited in over eight thousand peer-reviewed articles published in scientific journals, including the prestigious PNASCell, and Nature Medicine  journals

New Healthcare Consumer Survey Shows Continued Rise in Demand for Digital Access and Catalytic Impact of the COVID-19 Pandemic

BOSTON, MA, UNITED STATES - Oct 14, 2020 - Kyruus today announced findings from its fourth annual survey of 1,000 healthcare consumers exploring how they learn about, select, and schedule appointments with new providers

Momentum for AVIA Members Strong as Digital Transformation Accelerates

CHICAGO, MA, UNITED STATES - Oct 14, 2020 - While hospitals and health systems across the country face tremendous financial pressures and declining consumer confidence, AVIA Network Members continue to lead healthcare toward practical, impactful, and sustainable digital transformation

WCG Leads the Way and Sets a New Standard - Announcing the Formation of WCG IRB and the Launch of New WCG IRB Connexus™

PRINCETON, NJ - Oct 12, 2020 - WCG announced today the unification of its five industry-leading IRBs – Western IRB (WIRB), Copernicus Group IRB (CGIRB), Midlands IRB (MLIRB), New England IRB (NEIRB), and Aspire IRB – into the single WCG IRB brand

Mogrify introduces EpiMOGRIFY platform to systematically identify epigenetic switches driving cell identity and cell maintenance

CAMBRIDGE, UNITED KINGDOM - Dec 10, 2020 - Cambridge, UK, 9th October 2020: Mogrify Limited (Mogrify®), a UK company aiming to transform the development of ex vivo cell therapies and pioneer the field of in vivo reprogramming therapies, today announced the introduction of EpiMOGRIFY

Study Shows Proof of Concept of BioIVT HEPATOPAC Cultures with Targeted Assay to Evaluate Bioactivation Potential and Drug-induced Liver Injury (DILI) Risk

WESTBURY, NY - Oct 12, 2020 - BioIVT, a leading provider of research models and services for drug and diagnostic development, today announced the publication of research describing the use of HEPATOPAC® cultures with a targeted in vitro assay to identify small molecule drugs with high potential for drug-induced liver injury (DILI)
 1